ArticleCancer chemotherapy and pharmacology2026

NFE2L2 rs35652124C>T polymorphism predicts Grade 4 neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and fluorouracil chemotherapy: results from exploratory and validation cohorts.

Hisanaga Nomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.